This is to inform you that the Board of Directors of the Company have at their meeting held today, i.e. 19/06/2025 approved to incorporate a Company as a wholly owned subsidiary in United States of America.
Announcement under Regulation 30 (LODR)-Acquisition
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Issue of Securities
- Sudarshan Pharma Industries Ltd Press Release Jun 16 2025
- Board Meeting Intimation for Meeting Of The Board Of Directors To Be Held On Thursday, 19-June-2025
- Sudarshan Pharma Industries Ltd Press Release Jun 14 2025
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Later from Sudarshan Pharma Industries
- Sudarshan Pharma Industries Ltd Press Release Jun 19 2025
- Closure of Trading Window
- Sudarshan Pharma Industries Ltd Press Release Jun 30 2025
- Reg. 34 (1) Annual Report.
- Annual General Meeting On Friday, 25Th July 2025 At 3.00 P.M. IST
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries